CKD初级护理的治疗优化和护理依从性标准:TOSCA-CKD项目。

Q4 Medicine
Francesco Pesce, Domenico Pasculli, Giuseppe Castellano, Luca De Nicola, Giovanni Gambaro, Vincenzo Panichi, Domenico Santoro, Francesca Viazzi, Monica Zanella, Loreto Gesualdo
{"title":"CKD初级护理的治疗优化和护理依从性标准:TOSCA-CKD项目。","authors":"Francesco Pesce, Domenico Pasculli, Giuseppe Castellano, Luca De Nicola, Giovanni Gambaro, Vincenzo Panichi, Domenico Santoro, Francesca Viazzi, Monica Zanella, Loreto Gesualdo","doi":"10.69097/42-02-2025-10","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background.</b> Effective collaboration between general practitioners (GPs) and nephrologists is crucial for optimizing the management of chronic kidney disease (CKD). The TOSCA-CKD project (Treatment Optimization and Standard of Care Adherence in CKD Primary Care) aimed to evaluate the implementation of guidelines and the use of nephroprotective therapies in primary care. <b>Methods.</b> Clinical data were collected from the medical records of GPs across 12 Italian regions. The data were analyzed at baseline (T0) and after 6 months (T6) of collaboration with nephrologists. During this observational period, GPs were involved in remote education programs, which included expert-led webinars and clinical case-based learning. <b>Results.</b> A total of 76 GPs and 9 nephrologists were involved in the study, evaluating a cohort of 124,759 patients. There was an increase of 23.3% in the uACR test from T0 to T6 (3.0% vs. 3.7%; p < 0.001). Similarly, there was an increase of 15.2% in the use of eGFR from T0 to T6 (29.7% vs. 34.2%; p < 0.001). The rate of CKD diagnosis increased by 17.5% among patients with eGFR < 60 mL/min/1.73 m² (from 4% to 4.7%) and by 40% among patients with ACR > 30 mg/g (from 0.5% to 0.7%). The use of ACEi/ARBs remained stable at approximately 50%, while the treatment with SGLT2i, the new standard of care according to the current CKD guidelines, increased by 29.8% (from 4.7% to 6.1%). <b>Conclusions.</b> The TOSCA-CKD project demonstrated that GPs' remote educational program and a structured co-management approach significantly enhanced the early identification and improved the management of CKD in primary care.</p>","PeriodicalId":12553,"journal":{"name":"Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","volume":"42 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment Optimization and Standard of Care Adherence in CKD Primary Care: the TOSCA-CKD project.\",\"authors\":\"Francesco Pesce, Domenico Pasculli, Giuseppe Castellano, Luca De Nicola, Giovanni Gambaro, Vincenzo Panichi, Domenico Santoro, Francesca Viazzi, Monica Zanella, Loreto Gesualdo\",\"doi\":\"10.69097/42-02-2025-10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background.</b> Effective collaboration between general practitioners (GPs) and nephrologists is crucial for optimizing the management of chronic kidney disease (CKD). The TOSCA-CKD project (Treatment Optimization and Standard of Care Adherence in CKD Primary Care) aimed to evaluate the implementation of guidelines and the use of nephroprotective therapies in primary care. <b>Methods.</b> Clinical data were collected from the medical records of GPs across 12 Italian regions. The data were analyzed at baseline (T0) and after 6 months (T6) of collaboration with nephrologists. During this observational period, GPs were involved in remote education programs, which included expert-led webinars and clinical case-based learning. <b>Results.</b> A total of 76 GPs and 9 nephrologists were involved in the study, evaluating a cohort of 124,759 patients. There was an increase of 23.3% in the uACR test from T0 to T6 (3.0% vs. 3.7%; p < 0.001). Similarly, there was an increase of 15.2% in the use of eGFR from T0 to T6 (29.7% vs. 34.2%; p < 0.001). The rate of CKD diagnosis increased by 17.5% among patients with eGFR < 60 mL/min/1.73 m² (from 4% to 4.7%) and by 40% among patients with ACR > 30 mg/g (from 0.5% to 0.7%). The use of ACEi/ARBs remained stable at approximately 50%, while the treatment with SGLT2i, the new standard of care according to the current CKD guidelines, increased by 29.8% (from 4.7% to 6.1%). <b>Conclusions.</b> The TOSCA-CKD project demonstrated that GPs' remote educational program and a structured co-management approach significantly enhanced the early identification and improved the management of CKD in primary care.</p>\",\"PeriodicalId\":12553,\"journal\":{\"name\":\"Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia\",\"volume\":\"42 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.69097/42-02-2025-10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.69097/42-02-2025-10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景。全科医生(gp)和肾病学家之间的有效合作对于优化慢性肾脏疾病(CKD)的管理至关重要。TOSCA-CKD项目(CKD初级保健的治疗优化和护理依从性标准)旨在评估指南的实施和初级保健中肾保护疗法的使用。方法。临床数据是从意大利12个地区的全科医生的医疗记录中收集的。数据在基线(T0)和与肾病学家合作6个月(T6)后进行分析。在观察期间,全科医生参与了远程教育项目,其中包括专家领导的网络研讨会和基于临床病例的学习。结果。共有76名全科医生和9名肾病学家参与了这项研究,对124,759名患者进行了评估。从T0到T6, uACR试验增加了23.3% (3.0% vs. 3.7%;P < 0.001)。同样,从T0到T6, eGFR的使用增加了15.2% (29.7% vs. 34.2%;P < 0.001)。在eGFR < 60 mL/min/1.73 m²的患者中,CKD诊断率增加了17.5%(从4%增加到4.7%),在ACR < 30 mg/g的患者中,CKD诊断率增加了40%(从0.5%增加到0.7%)。ACEi/ arb的使用保持稳定在50%左右,而SGLT2i治疗,根据当前CKD指南的新护理标准,增加了29.8%(从4.7%增加到6.1%)。结论。TOSCA-CKD项目表明,全科医生的远程教育计划和结构化的共同管理方法显著提高了初级保健中CKD的早期识别和管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Treatment Optimization and Standard of Care Adherence in CKD Primary Care: the TOSCA-CKD project.

Background. Effective collaboration between general practitioners (GPs) and nephrologists is crucial for optimizing the management of chronic kidney disease (CKD). The TOSCA-CKD project (Treatment Optimization and Standard of Care Adherence in CKD Primary Care) aimed to evaluate the implementation of guidelines and the use of nephroprotective therapies in primary care. Methods. Clinical data were collected from the medical records of GPs across 12 Italian regions. The data were analyzed at baseline (T0) and after 6 months (T6) of collaboration with nephrologists. During this observational period, GPs were involved in remote education programs, which included expert-led webinars and clinical case-based learning. Results. A total of 76 GPs and 9 nephrologists were involved in the study, evaluating a cohort of 124,759 patients. There was an increase of 23.3% in the uACR test from T0 to T6 (3.0% vs. 3.7%; p < 0.001). Similarly, there was an increase of 15.2% in the use of eGFR from T0 to T6 (29.7% vs. 34.2%; p < 0.001). The rate of CKD diagnosis increased by 17.5% among patients with eGFR < 60 mL/min/1.73 m² (from 4% to 4.7%) and by 40% among patients with ACR > 30 mg/g (from 0.5% to 0.7%). The use of ACEi/ARBs remained stable at approximately 50%, while the treatment with SGLT2i, the new standard of care according to the current CKD guidelines, increased by 29.8% (from 4.7% to 6.1%). Conclusions. The TOSCA-CKD project demonstrated that GPs' remote educational program and a structured co-management approach significantly enhanced the early identification and improved the management of CKD in primary care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.70
自引率
0.00%
发文量
62
期刊介绍: Il Giornale Italiano di Nefrologia (GIN) è la rivista di educazione continua della Società Italiana di Nefrologia SIN ed è pubblicato bimestralmente. E" il più autorevole organo di informazione nefrologia disponibile a livello nazionale. Il giornale Italiano di Nefrologia offre la più aggiornata informazione medico-scientifica rivolta al nefrologo sotto forma di rassegne, casi clinici e articoli finalizzati all’Educazione Continua in Medicina, oltre ai notiziari ed agli atti dei congressi di questa prestigiosa Società Scientifica
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信